In a recent study, UCLA researchers discovered that a newly-approved melanoma drug accelerates secondary skin cancers in some patients. In this radio report from KPCC, listen to Jonsson Comprehensive Cancer Center scientist and co-senior author of the study Dr. Antoni Ribas discuss why the findings are actually potentially good news for the future of melanoma drug treatments.

Listen to the audio.

(Note: The above file require an MP3 player such as RealPlayer, QuickTime, or Windows Media Player.)